James A. Schoeneck
Overview
James A. Schoeneck received an average of $3M in total compensation, including $382K in salary, at FibroGen between 2019 and 2020. James Schoeneck also received an average of $4M at DepoMed from 2011 to 2017.
- 2020
- 2019
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
FibroGenInterim Chief Executive Officer
FibroGenInterim Chief Executive Officer
DepoMedFormer President and Chief Executive Officer
DepoMedFormer President and Chief Executive Officer
DepoMedFormer President and Chief Executive Officer
DepoMedFormer President and Chief Executive Officer
DepoMedPresident and Chief Executive Officer
DepoMedPresident and Chief Executive Officer
DepoMedPresident and Chief Executive Officer
Source: SEC filings on April 13, 2021, April 23, 2020, March 27, 2018, July 14, 2017, April 14, 2016, April 6, 2015, and April 4, 2014.
Related executives
We found 27 more executives who work or worked at FibroGen and DepoMed.
Enrique Conterno
FibroGen
Chief Executive Officer
Christine Chung
FibroGen
Senior Vice President, China Operations
Mark Eisner
FibroGen
Chief Medical Officer
Pat Cotroneo
FibroGen
Chief Financial Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Thane Wettig
FibroGen
Chief Commercial Officer
Juan Graham
FibroGen
Chief Financial Officer
K Yu
FibroGen